FK 506 and aminoguanidine suppress iNOS induction in orthotopic corneal allografts and prolong graft survival in mice

Nitric Oxide - Biology and Chemistry

Volumn 9, Issue 2, 2003, Pages 111-117

  Strestikova, P ^a   Plskova J ^a   Filipec, M ^a   Farghali, H ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Aminoguanidine; Corneal allogeneic transplantation; FK 506; Immunological rejection; Inducible nitric oxide synthase; Macrophages

Indexed keywords

AMINOGUANIDINE; IMMUNOSUPPRESSIVE AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; TACROLIMUS; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME REPRESSION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MALE; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALIA;

EID: 0242493604     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2003.08.003     Document Type: Article

References (35)

1. Niederkorn J.Y. The immune privilege of corneal allografts. Transplantation. 67:1999;1503-1508.
2. Williams K.A., Muehlberg S.M., Lewis R.F., Coster D.J. How successful is corneal transplantation? A report from the Australian corneal graft register. Eye. 9:1995;219-227.
3. G.N. Foulks, J.Y. Niederkorn, F. Sanfilippo, in: J.S. Pepose, G.N. Holland, K.R. Wilhelmus (Eds.), Mosby, St. Louis, 1996, p. 435.
4. Stark W., Stulting D., Mauguire M.et al. The collaborative corneal transplantation studies corneal transplantation studies (CCTS): effectiveness of histocompatibility matching of donors and recipients in high-risk corneal transplantation. Arch. Ophthalmol. 110:1992;1392-1403.
5. Bouchard C.S., Cavanagh H.D. The high-risk keratoplasty patient - Quo vadis? Cornea. 13:1994;1-3.
6. Kuffová L., Veselá V., Filipec M., Holáň V., Lumsden L., Forrester J.V. Cell subpopulation in failed human corneal grafts. Br. J. Ophthalmol. 83:1999;1364-1369.
7. Holland E.J., Olsen T.W., Chan C.C., Bergstrom L., Palestine A.G., Nussenblatt R.B. Kinetics of corneal transplant rejection in the rat penetrating keratoplasty model. Cornea. 13:1994;317-323.
8. Joo C.K., Pepose J.S., Stuart P.M. T-cell mediated responses in a murine model of orthotopic corneal transplants in mice. Invest. Ophthalmol. Vis. Sci. 36:1995;1530-1540.
9. Yamamoto N., Einaga-Naito K., Kuriyama M., Kawada Y., Yoshida R. Cellular basis of skin allograft rejection in mice: specific lysis of allogeneic skin components by non-T cells. Transplantation. 65:1998;818-825.
10. Ignarro L.J. Nitric oxide. A novel signal transduction mechanism for transcellular communication. Hypertension. 16:1990;477-483.
11. Li J., Billiar T.R. Nitric oxide IV. Determinants of nitric oxide protection and toxicity in liver. Am. J. Physiol. 276:1999;1069-1073. Gastrointest. Liver Physiol. 39.
12. Marletta M.A., Yoon P.S., Iyengar R., Leaf C.D., Wishnok J.S. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry. 27:1988;8706-8711.
13. Knowles R.G., Moncada S. Nitric oxide synthases in mammals. Biochem. J. 298:1994;249-258.
14. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
15. Stuehr D.J., Marletta M.A. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 82:1985;7738-7742.
16. Curran R.D., Billiar T.R., Stuehr D.J., Hoffmann K., Simmons R.L. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J. Exp. Med. 170:1989;1769-1774.
17. Lorsbach R.B., Russell S.W. A specific sequence of stimulation is required to induce synthesis of the antimicrobial molecule nitric oxide by mouse macrophages. Infect. Immunol. 60:1992;2133-2135.
18. Nussler A.K., Di Silvio M., Billiar T.R., Hoffman R.A., Geller D.A., Selby R., Madariage J., Simmons R.L. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med. 176:1992;261-264.
19. Lancaster J.R., Langrehr J.M., Bergonia H.A., Murase N., Simmons R.L., Hoffman R.A. EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J. Biol. Chem. 267:1992;10994-10998.
20. Kino T., Hatanaka H., Hashimoto M., Nishiyama M., Goto T., Okuhara M., Kohsaka M., Aoki H., Imanaka H. FK 506, anovel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J. Antibiot. 40:1987;1249-1255.
21. Kino T., Hatanaka H., Susumu M., Inamura N., Nishiyama M., Yajima T., Goto T., Okuhara M., Kohsaka M., Aoki H., Ochiai T. FK 506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK 506 in vitro. J. Antibiot. 40:1987;1256-1265.
22. Taylor B.S., Liu S., Villavicencio R.T., Ganster R.W., Geller D.A. The role of protein phosphatases in the expression of inducible nitric oxide synthase in the rat. Hepatocyte. 29:1999;1199-1207.
23. Misko T.P., Moore W.M., Kasten T.P., Nickols G.A., Corbett J.A., Tilton R.G., McDaniel M.L., Williamson J.R., Currie M.G. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233:1993;119-125.
24. Okamoto T., Masuda Y., Kawasaki T., Shinohara M., Matsukazi K. Aminoguanidine prevents concanavalin A-induced hepatitis in mice. Eur. J. Pharmacol. 396:2000;125-130.
25. She S.C., Steahly L.P., Moticka E.J. A method for performing full-thickness, orthotopic, penetrating keratoplasty in the mouse. Ophthalmic Surg. Lasers. 21:1990;781-785.
26. Pleyer U., Dannowski H., Volk H.D., Ritter T. Corneal allograft rejection: current understanding. Ophthalmologica. 215:2001;254-262.
27. Kolb H., Kolb-Bachofen V. Nitric oxide in autoimmune disease: cytotoxic or regulatory. Immunol. Today. 19:1998;556-561.
28. Hašková Z., Filipec M., Holáň V. The role of major and minor histocompatibility antigens in orthotopic corneal transplantation in mice. Folia Biol. 42:1996;105-111.
29. Streilein J.W., Wilbanks G.A., Cousins S.W. Immunoregulatory mechanisms of the eye. J. Neuroimmunol. 39:1992;185-200.
30. Vodovotz Y., Bodgan C., Paik J., Xie Q., Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β J. Exp. Med. 178:1993;605-613.
31. Cooper M., Lindholm P., Pieper G., Seibel R., Moore G., Nakanishi A., Dembny K., Komorowski R., Johnson C., Adams M., Roza A. Myocardial nuclear factor-κB activity and nitric oxide production in rejecting cardiac allografts. Transplantation. 66:1998;838-844.
32. Szabolcs M.J., Michler R.E., Yang X., Aji W., Roy D., Athan E., Sciacca R.R., Minanov O.P., Cannon P.J. Apoptosis of cardiac myocytes during cardiac allograft rejection: relation to induction of nitric oxide synthase. Circulation. 94:1996;1665-1673.
33. Ichiguchi O., Yamaguchi Y., Goto M., Matsamura F., Miyanari N., Akizuki E., Matsuda T., Okabe K., Liang J., Ohshiro H., Mori K., Ogawa M. A significant reduction of macrophages expressing inducible nitric oxide synthase in rat hepatic allografts pretreated with donor-specific blood. Transplantation. 65:1998;776-785.
34. Wang X., Lewis D.A., Kim H., Tazelaar H.D., Park Y., McGregor C.G.A., Miller V.M. Alternation in mRNA for inducible and endothelial nitric oxide synthase and plasma nitric oxide with rejection and/or infection of allotransplanted lungs. Transplantation. 66:1998;567-572.
35. Střeštíková P., Otová B., Filipec M., Mašek K., Farghali H. Different mechanisms in inhibition of rat macrophage nitric oxide synthase expression by FK 506 and cyclosporine A. Immunopharmacol. Immunotoxicol. 23:2001;67-74.